| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/19/2006 | CN1252087C Tetramer combined with SARS antigen peptide and its preparation and use |
| 04/19/2006 | CN1252086C Polypeptide and use thereof |
| 04/19/2006 | CN1252085C Peptide as VEGF receptor KDR antagonist |
| 04/19/2006 | CN1252084C Purification of tetramucoprotein as protein label for early dianosis of oophoroma |
| 04/19/2006 | CN1251761C Vaccine comprising cytokine-induced heat shock proteins |
| 04/18/2006 | US7030303 Hybrid maize 38B85 |
| 04/18/2006 | US7030302 Inbred corn line PHBBP |
| 04/18/2006 | US7030296 Toxin gene from the bacteria photorhabdus luminescens |
| 04/18/2006 | US7030295 Plant fungicide, pesticides, insecticides; insertion protease detectors; corn |
| 04/18/2006 | US7030293 Methods of inducing resistance in plants to fungal pathogens by transformation with acquired genes |
| 04/18/2006 | US7030291 CYT28 serpentine receptor disruptions, compositions and methods relating thereto |
| 04/18/2006 | US7030289 Protection of proteins (e.g. fibrinogen) expressed in milk from transgenic animals by co-expression of a serine proteinase inhibitor (e.g. alpha 1-antitrypsin) in the milk of the transgenic animals. |
| 04/18/2006 | US7030235 Nucleic acid primer or probe in a kit, for diagnosing a hearing disorder due to gene defects; encoding a protein with an amino acid at target position residue; monoclonal antibody; gene therapy, biodrugs |
| 04/18/2006 | US7030234 Non-M, non-O HIV-1 strains, fragments and uses |
| 04/18/2006 | US7030233 Microorganism for use as cloning tool in genetic engineering |
| 04/18/2006 | US7030232 E25A protein, methods for producing and use thereof |
| 04/18/2006 | US7030226 Fc fusion proteins of human erythropoietin with increased biological activities |
| 04/18/2006 | US7030225 Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies |
| 04/18/2006 | US7030224 Human cytoplasmic polyadenylation element binding protein and uses thereof |
| 04/18/2006 | US7030223 Novel protein factors which share homologous sequences and biological activities with megakaryocyte colony-stimulating factor (meg-CSF); genetic engineering |
| 04/18/2006 | US7030222 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 04/18/2006 | US7030221 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of nervous system disorders |
| 04/18/2006 | US7030219 Nucleotide sequences coding protein for use in treatment of cancer and prevention of viral infection |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030213 Conformationally stabilized cell adhesion peptides |
| 04/18/2006 | US7030212 Tumor antigen based on products of the tumor suppressor gene WT1 |
| 04/18/2006 | US7030099 Tumor specific promoters of the midkine gene that allow for selective expression in P53-inactivated cells |
| 04/18/2006 | US7030098 DNA vaccination for treatment of autoimmune disease |
| 04/18/2006 | US7030088 Human secreted hemopexin-related proteins |
| 04/18/2006 | US7030087 A water-soluble polypeptide having hydrophobic side chains, for use as bactericides treating infections, detoxification of endotoxin, cell antiproliferative agents, antagonist of tumor necrosis factor |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7030084 Drug-oligomer conjugates with polyethylene glycol components |
| 04/18/2006 | US7030083 Prevention and treatment of endothelial injury and the injury of tissues containing injured blood vessels by administration of vascular endothelial cell growth factor |
| 04/18/2006 | US7030081 Muteins of the Ser-Cys-Asn-Thr-Ala-Thr-Cys sequence from the N- terminal 1-7 fragment of the CGRP (calcitonin gene related peptide), activates neuronal nicotinic receptor, therefor useful for therapy of neurological disorders |
| 04/18/2006 | US7030080 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 04/18/2006 | US7029917 Controlling endosperm development |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029911 AFC1 and RCE1: isoprenylated CAAX processing enzymes |
| 04/18/2006 | US7029909 Trypsin secretory signal peptide; nucleotide sequences; splitting using kinase; cloning |
| 04/18/2006 | US7029904 Polynucleotide sequences which code enzymatic polypeptide for use generation of preferential amino acid for use in human medicine, foods and animal nutrients |
| 04/18/2006 | US7029901 Peptide for use in the treatment of inflammation, cancer and arteriosclerosis |
| 04/18/2006 | US7029895 Comprises nucleotide sequences coding cardiolipin for diagnosis and treatment of lung, heart and respiratory disorders |
| 04/18/2006 | US7029894 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/18/2006 | US7029893 for producing amino acids in microorganisms having enhanced or attenuated expression; genetic engineering |
| 04/18/2006 | US7029890 Tyrosylprotein sulfotransferases and methods of use thereof |
| 04/18/2006 | US7029878 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029876 Process for production of polypeptides |
| 04/18/2006 | US7029874 Comprises nucleotide sequences coding membrane proteins for treatment and diagnosis cell proliferative, inflammatory, autoimmune and nervous system disorders |
| 04/18/2006 | US7029873 Nucleic acids to PRO1387 polypeptides |
| 04/18/2006 | US7029871 Polypeptide for use in screening chemical libraries for lead compounds and for use in human therapeutics |
| 04/18/2006 | US7029865 Nucleotide sequences coding G-protein coupled receptors (MC-4R) for treating obesity and eating disorders |
| 04/18/2006 | US7029862 Method for identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 |
| 04/18/2006 | US7029861 detection mutants; drug screening; stimulant tumor necrosis factor; |
| 04/18/2006 | US7029860 Amyloid-β protein aggregation-regulating factors |
| 04/18/2006 | US7029859 Sequences for targeting metastatic cells |
| 04/18/2006 | US7029858 Genetic engineering; binding collagen to integrins; vaccine |
| 04/18/2006 | US7029857 Isolated nucleic acids; competitive binding |
| 04/18/2006 | US7029853 Nucleotide sequences for detection of Bacillus anthracis |
| 04/18/2006 | US7029851 Polynucleotide encoding a gene conferring resistance to Bacillus thuringiensis toxins |
| 04/18/2006 | US7029849 Kit for use in the diagnosis of hypertension; obtain sample, determine pattern of alleles, detect preferential gene expression, preferential gene expression indicates hypertension |
| 04/18/2006 | US7029846 Site-specific protein modification |
| 04/18/2006 | US7029845 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses |
| 04/18/2006 | US7029713 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 04/18/2006 | US7029686 Variants of Phleum pratense allergenic proteins |
| 04/18/2006 | US7029685 Plasmodium falciparum AMA-1 protein and uses thereof |
| 04/18/2006 | US7029684 Antigenic composition of a Pseudomonas aeruginosa |
| 04/18/2006 | US7029681 Multiple and multivalent DNA vaccines in ovo |
| 04/18/2006 | US7029679 Variant of LAV viruses |
| 04/18/2006 | US7029677 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 04/18/2006 | US7029676 Peptide composition for us e in the treatment of psoriasis |
| 04/18/2006 | US7029674 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 04/18/2006 | US7029673 Regulatory protein for Nox enzymes |
| 04/18/2006 | US7029668 Endothelium gene expression opf core protein; Dna sequences; transfection; binding to heparan sulfate |
| 04/18/2006 | US7029667 encodes a protein or polypeptide which elicits a hyersensitive response in plants; used to impart disease resistance to plants, to enhance plant growth, and/or to control insects on plants |
| 04/18/2006 | US7029664 Chicken leukemia inhibitory factor (LIF) |
| 04/13/2006 | WO2006039717A2 Methods of determining precise herg interactions and altering compounds based on said interactions |
| 04/13/2006 | WO2006039707A2 Domain ii mutants of anthrax lethal factor |
| 04/13/2006 | WO2006039652A2 Chondroitin sulfate a binding domains |
| 04/13/2006 | WO2006039621A2 Novel modification of immunomodulatory protein |
| 04/13/2006 | WO2006039604A1 Use of pregnancy specific glycoprotein for maturation of oocytes |
| 04/13/2006 | WO2006039592A1 Use of il-17- for maturation of oocytes |
| 04/13/2006 | WO2006039588A2 Devices and methods for integrated continuous manufacturing of biological molecules |
| 04/13/2006 | WO2006039533A2 Bcr-abl imatinib resistance-associated peptides and methods of use thereof |
| 04/13/2006 | WO2006039367A2 Resonance energy transfer system and method |
| 04/13/2006 | WO2006039136A2 Methods and compositions for beta conglycinin fraction of soy protein |
| 04/13/2006 | WO2006038908A2 Ancestral and cot viral sequences, proteins and immunogenic compositions |
| 04/13/2006 | WO2006038729A1 Mutated amyloid protein |
| 04/13/2006 | WO2006038007A2 Inhibitory analogues to block receptors for microbial pathogenic determinants |
| 04/13/2006 | WO2006037960A2 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
| 04/13/2006 | WO2006037811A2 Protracted exendin-4 compounds |
| 04/13/2006 | WO2006037807A2 Identification of regions of apical membrane antigen 1 of apicomplexan parasites suitable for targeting by vaccines and drugs by derivation and analysis of the three-dimensional structure |
| 04/13/2006 | WO2006037800A1 COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE |
| 04/13/2006 | WO2006037770A1 Covalent grafting of hydrophobic substances on collagen |
| 04/13/2006 | WO2006037744A1 Deglycosylated and desialidated long pentraxin ptx3 |
| 04/13/2006 | WO2006037655A2 Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes |
| 04/13/2006 | WO2006037570A2 Protein assay of type sglt1 |
| 04/13/2006 | WO2006037513A1 Diagnostics and therapeutics for diseases associated with matrix metalloproteinase 9 (mmp9) |
| 04/13/2006 | WO2006037421A2 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 04/13/2006 | WO2006037383A1 Piscirickettsia salmonis antigens and use thereof |